Quince Therapeutics (QNCX)

• Market cap: $19.8M
• 1 day: -8.18%
• 5 days: -12.17%
• 1 month: -17.89%
• 3 months: -7.34%
• 6 months: -97.48%
• Year to date: -96.63%
• 1 year: -91.51%
• 5 years: -99.77%
• 10 years: -99.69%
• Sector: Healthcare
• Industry: Biotechnology

About: Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Employees: 38